Role of interferon regulatory factor 1 in induction of nitric oxide synthase - PubMed (original) (raw)
Role of interferon regulatory factor 1 in induction of nitric oxide synthase
E Martin et al. J Exp Med. 1994.
Abstract
Interferon gamma (IFN-gamma) interacts synergistically with bacterial lipopolysaccharide (LPS) to induce transcription of iNOS, the isoform of nitric oxide synthase whose activity is independent of elevated Ca2+ and exogenous calmodulin. To define a cis-acting element mediating IFN-gamma-dependent synergy, we made deletions in iNOS promoter constructs fused to reporter genes, transfected RAW 264.7 macrophages, and treated the cells with IFN-gamma and/or LPS. This analysis implicated the region from positions -951 to -911, a cluster of four enhancer elements known to bind IFN-gamma-responsive transcription factors, including an interferon regulatory factor binding site (IRF-E) at nucleotides -913 to -923. Site-specific substitution of two conserved nucleotides within IRF-E in the context of the full-length iNOS promoter ablated IFN-gamma's contribution to synergistic enhancement of transcription. Electromobility shift assays performed with a probe containing IRF-E revealed the existence of a complex in nuclei of RAW 264.7 macrophages that was present only after treatment with IFN-gamma, which reacted specifically with anti-IRF-1 immunoglobulin G and which included a species migrating at 40-45 kD, consistent with the apparent molecular weight of murine IRF-1. Thus, the synergistic contribution of IFN-gamma to transcription of iNOS in RAW 264.7 macrophages requires that IRF-1 bind to IRF-E in the iNOS promoter. In conjunction with the work of Kamijo et al. (Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, K. S. Im, T. Kimura, S. Green et al. 1994. Science [Wash. DC]. 263:1612), these findings identify iNOS as the first gene that requires IRF-1 for IFN-gamma-dependent transcriptional regulation.
Similar articles
- Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide.
Xie QW, Whisnant R, Nathan C. Xie QW, et al. J Exp Med. 1993 Jun 1;177(6):1779-84. doi: 10.1084/jem.177.6.1779. J Exp Med. 1993. PMID: 7684434 Free PMC article. - Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine.
Weisz A, Cicatiello L, Esumi H. Weisz A, et al. Biochem J. 1996 May 15;316 ( Pt 1)(Pt 1):209-15. doi: 10.1042/bj3160209. Biochem J. 1996. PMID: 8645207 Free PMC article. - Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes.
Kinugawa K, Shimizu T, Yao A, Kohmoto O, Serizawa T, Takahashi T. Kinugawa K, et al. Circ Res. 1997 Dec;81(6):911-21. doi: 10.1161/01.res.81.6.911. Circ Res. 1997. PMID: 9400371 - Phorbol ester synergistically increases interferon regulatory factor-1 and inducible nitric oxide synthase induction in interferon-gamma-treated RAW 264.7 cells.
Momose I, Terashima M, Nakashima Y, Sakamoto M, Ishino H, Nabika T, Hosokawa Y, Tanigawa Y. Momose I, et al. Biochim Biophys Acta. 2000 Oct 20;1498(1):19-31. doi: 10.1016/s0167-4889(00)00072-0. Biochim Biophys Acta. 2000. PMID: 11042347 - Involvement of nitric oxide synthase in antiproliferative activity of macrophages: induction of the enzyme requires two different kinds of signal acting synergistically.
Chénais B, Tenu JP. Chénais B, et al. Int J Immunopharmacol. 1994 May-Jun;16(5-6):401-6. doi: 10.1016/0192-0561(94)90028-0. Int J Immunopharmacol. 1994. PMID: 7523317 Review.
Cited by
- IFN-γ lowers tumor growth by increasing glycolysis and lactate production in a nitric oxide-dependent manner: implications for cancer immunotherapy.
Chattopadhyay A, Jagdish S, Karhale AK, Ramteke NS, Zaib A, Nandi D. Chattopadhyay A, et al. Front Immunol. 2023 Oct 27;14:1282653. doi: 10.3389/fimmu.2023.1282653. eCollection 2023. Front Immunol. 2023. PMID: 37965321 Free PMC article. - The Role of Interferon Regulatory Factor 1 in Regulating Microglial Activation and Retinal Inflammation.
Yang X, Diaz V, Huang H. Yang X, et al. Int J Mol Sci. 2022 Nov 24;23(23):14664. doi: 10.3390/ijms232314664. Int J Mol Sci. 2022. PMID: 36498991 Free PMC article. - Isolation of mouse mammary carcinoma-derived macrophages and cancer cells for co-culture assays.
Sun L, Han X, Egeblad M. Sun L, et al. STAR Protoc. 2022 Nov 10;3(4):101833. doi: 10.1016/j.xpro.2022.101833. eCollection 2022 Dec 16. STAR Protoc. 2022. PMID: 36386879 Free PMC article. - Inhibition of LPS-Induced Microglial Activation by the Ethyl Acetate Extract of Pueraria mirifica.
Jantaratnotai N, Thampithak A, Utaisincharoen P, Pinthong D, Sanvarinda P. Jantaratnotai N, et al. Int J Environ Res Public Health. 2022 Oct 9;19(19):12920. doi: 10.3390/ijerph191912920. Int J Environ Res Public Health. 2022. PMID: 36232220 Free PMC article. - Mitogen-activated protein kinase phosphatase-1 controls PD-L1 expression by regulating type I interferon during systemic Escherichia coli infection.
Barley TJ, Murphy PR, Wang X, Bowman BA, Mormol JM, Mager CE, Kirk SG, Cash CJ, Linn SC, Meng X, Nelin LD, Chen B, Hafner M, Zhang J, Liu Y. Barley TJ, et al. J Biol Chem. 2022 May;298(5):101938. doi: 10.1016/j.jbc.2022.101938. Epub 2022 Apr 13. J Biol Chem. 2022. PMID: 35429501 Free PMC article.
References
- J Exp Med. 1994 Feb 1;179(2):651-60 - PubMed
- Mol Cell Biol. 1994 Feb;14(2):1322-32 - PubMed
- Science. 1994 Mar 18;263(5153):1612-5 - PubMed
- J Immunol. 1994 Apr 15;152(8):4110-8 - PubMed
- J Biol Chem. 1994 May 13;269(19):13725-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous